BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37094569)

  • 1. Volatolomics analysis of exhaled breath and gastric-endoluminal gas for distinguishing early upper gastrointestinal cancer from benign.
    Xiang C; Yang H; Zhao Z; Deng F; Lv Y; Yang Y; Duan Y; Li W; Hu B
    J Breath Res; 2023 May; 17(3):. PubMed ID: 37094569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass-Spectrometry Analysis of Mixed-Breath, Isolated-Bronchial-Breath, and Gastric-Endoluminal-Air Volatile Fatty Acids in Esophagogastric Cancer.
    Adam ME; Fehervari M; Boshier PR; Chin ST; Lin GP; Romano A; Kumar S; Hanna GB
    Anal Chem; 2019 Mar; 91(5):3740-3746. PubMed ID: 30699297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Targeted and Untargeted Approaches in Breath Analysis for the Discrimination of Lung Cancer from Benign Pulmonary Diseases and Healthy Persons.
    Koureas M; Kalompatsios D; Amoutzias GD; Hadjichristodoulou C; Gourgoulianis K; Tsakalof A
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33946997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma.
    Kumar S; Huang J; Abbassi-Ghadi N; Mackenzie HA; Veselkov KA; Hoare JM; Lovat LB; Španěl P; Smith D; Hanna GB
    Ann Surg; 2015 Dec; 262(6):981-90. PubMed ID: 25575255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exhaled breath analysis using on-line preconcentration mass spectrometry for gastric cancer diagnosis.
    Hong Y; Che X; Su H; Mai Z; Huang Z; Huang W; Chen W; Liu S; Gao W; Zhou Z; Tan G; Li X
    J Mass Spectrom; 2021 Apr; 56(4):e4588. PubMed ID: 32633879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
    Dallinga JW; Smolinska A; van Schooten FJ
    Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive detection of lung cancer by analysis of exhaled breath.
    Bajtarevic A; Ager C; Pienz M; Klieber M; Schwarz K; Ligor M; Ligor T; Filipiak W; Denz H; Fiegl M; Hilbe W; Weiss W; Lukas P; Jamnig H; Hackl M; Haidenberger A; Buszewski B; Miekisch W; Schubert J; Amann A
    BMC Cancer; 2009 Sep; 9():348. PubMed ID: 19788722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions.
    Xu ZQ; Broza YY; Ionsecu R; Tisch U; Ding L; Liu H; Song Q; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD; Leja M; Haick H
    Br J Cancer; 2013 Mar; 108(4):941-50. PubMed ID: 23462808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an Exhaled Breath Monitoring System with Semiconductive Gas Sensors, a Gas Condenser Unit, and Gas Chromatograph Columns.
    Itoh T; Miwa T; Tsuruta A; Akamatsu T; Izu N; Shin W; Park J; Hida T; Eda T; Setoguchi Y
    Sensors (Basel); 2016 Nov; 16(11):. PubMed ID: 27834896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geographical variation in the exhaled volatile organic compounds.
    Amal H; Leja M; Broza YY; Tisch U; Funka K; Liepniece-Karele I; Skapars R; Xu ZQ; Liu H; Haick H
    J Breath Res; 2013 Dec; 7(4):047102. PubMed ID: 24184568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm.
    Sakumura Y; Koyama Y; Tokutake H; Hida T; Sato K; Itoh T; Akamatsu T; Shin W
    Sensors (Basel); 2017 Feb; 17(2):. PubMed ID: 28165388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaled volatolomics profiling facilitates personalized screening for gastric cancer.
    Chen J; Ji Y; Liu Y; Cen Z; Chen Y; Zhang Y; Li X; Li X
    Cancer Lett; 2024 May; 590():216881. PubMed ID: 38614384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of an Exhaled Breath Test Using High-Pressure Photon Ionization Time-of-Flight Mass Spectrometry to Detect Lung Cancer.
    Meng S; Li Q; Zhou Z; Li H; Liu X; Pan S; Li M; Wang L; Guo Y; Qiu M; Wang J
    JAMA Netw Open; 2021 Mar; 4(3):e213486. PubMed ID: 33783517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer.
    Kumar S; Huang J; Abbassi-Ghadi N; Španěl P; Smith D; Hanna GB
    Anal Chem; 2013 Jun; 85(12):6121-8. PubMed ID: 23659180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal chemometric approach for the analysis of human exhaled breath in lung cancer patients by TD-GC × GC-TOFMS.
    Pesesse R; Stefanuto PH; Schleich F; Louis R; Focant JF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 May; 1114-1115():146-153. PubMed ID: 30745111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculated indices of volatile organic compounds (VOCs) in exhalation for lung cancer screening and early detection.
    Chen X; Muhammad KG; Madeeha C; Fu W; Xu L; Hu Y; Liu J; Ying K; Chen L; Yurievna GO
    Lung Cancer; 2021 Apr; 154():197-205. PubMed ID: 33653598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
    De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF
    J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.